📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR). (2017)

First Author: Seckl MJ

Attributed to: MICA: Immunotherapy for oral cancer prevention and treatment funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.2016.69.7391

PubMed Identifier: 28240967

Publication URI: http://europepmc.org/abstract/MED/28240967

Type: Journal Article/Review

Volume: 35

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 14

ISSN: 0732-183X